All In MedTech

Device Trial Radar · NCT05686330

Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch)

Enhanced Detection and Quickened Diagnosis of Atrial Fibrillation Using the Apple Watch: A Randomised Controlled Trial (EQUAL Study)

Last checked: Nov 19, 2026Latest source record: Sep 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 436 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

436

Actual

Start

Nov 16, 2022

Primary completion

Jul 17, 2025

Study completion Jul 17, 2025

Sponsor

Sponsor type
Academic, hospital or other
First posted
Jan 17, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized controlled trial evaluating atrial fibrillation (AF) detection through smartwatch-based screening in high-risk patients using an Apple Watch with integrated PPG and ECG functions.

Conditions

  • Atrial Fibrillation

Interventions

  • Apple WatchDevice

    Smartwatch for detecting atrial fibrillation using photoplethysmography (PPG)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence of atrial fibrillationTime frame: 6 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Cardiology Center of the Netherlands

    Amsterdam, North Holland, Netherlands

  • Spaarne Gasthuis

    Haarlem, North Holland, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.